BHAVNISH PARIKH

Person

AVONDALE, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Sustained-release dosage forms of ruxolitinib
- Patent number 11,896,717
- Issue date Feb 13, 2024
- Incyte Holdings Corporation
- Yong Ni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Topical formulation for a JAK inhibitor
- Patent number 11,590,136
- Issue date Feb 28, 2023
- Incyte Corporation
- Bhavnish Parikh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sustained-release dosage forms of ruxolitinib
- Patent number 11,576,865
- Issue date Feb 14, 2023
- Incyte Corporation
- Yong Ni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sustained-release dosage forms of ruxolitinib
- Patent number 11,576,864
- Issue date Feb 14, 2023
- Incyte Corporation
- Yong Ni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Topical formulation for a JAK inhibitor
- Patent number 11,571,425
- Issue date Feb 7, 2023
- Incyte Corporation
- Bhavnish Parikh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sustained-release dosage forms of ruxolitinib
- Patent number 11,337,927
- Issue date May 24, 2022
- Incyte Holdings Corporation
- Yong Ni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Topical formulation for a JAK inhibitor
- Patent number 11,219,624
- Issue date Jan 11, 2022
- Incyte Holdings Corporation
- Bhavnish Parikh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sustained release dosage forms for a JAK1 inhibitor
- Patent number 11,045,421
- Issue date Jun 29, 2021
- Incyte Corporation
- Krishnaswamy Yeleswaram
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sustained-release dosage forms of ruxolitinib
- Patent number 10,874,616
- Issue date Dec 29, 2020
- Incyte Corporation
- Yong Ni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Topical formulation for a JAK inhibitor
- Patent number 10,869,870
- Issue date Dec 22, 2020
- Incyte Corporation
- Bhavnish Parikh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Topical formulation for a JAK inhibitor
- Patent number 10,758,543
- Issue date Sep 1, 2020
- Incyte Corporation
- Bhavnish Parikh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sustained release dosage forms for a JAK1 inhibitor
- Patent number 10,561,616
- Issue date Feb 18, 2020
- Incyte Corporation
- Krishnaswamy Yeleswaram
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sustained-release dosage forms of ruxolitinib
- Patent number 10,166,191
- Issue date Jan 1, 2019
- Incyte Corporation
- Yong Ni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sustained release dosage forms for a JAK1 inhibitor
- Patent number 9,655,854
- Issue date May 23, 2017
- Incyte Corporation
- Krishnaswamy Yeleswaram
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TOPICAL FORMULATION FOR A JAK INHIBITOR
- Publication number 20240245687
- Publication date Jul 25, 2024
- Incyte Holdings Corporation
- Bhavnish Parikh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOPICAL FORMULATION FOR A JAK INHIBITOR
- Publication number 20230277541
- Publication date Sep 7, 2023
- INCYTE CORPORATION
- Bhavnish Parikh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB
- Publication number 20230136579
- Publication date May 4, 2023
- INCYTE CORPORATION
- Yong Ni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOPICAL FORMULATION FOR A JAK INHIBITOR
- Publication number 20220378792
- Publication date Dec 1, 2022
- INCYTE CORPORATION
- Bhavnish Parikh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOPICAL FORMULATION FOR A JAK INHIBITOR
- Publication number 20220370455
- Publication date Nov 24, 2022
- INCYTE CORPORATION
- Bhavnish Parikh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB
- Publication number 20220331253
- Publication date Oct 20, 2022
- INCYTE CORPORATION
- Yong Ni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB
- Publication number 20220323363
- Publication date Oct 13, 2022
- INCYTE CORPORATION
- Yong Ni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOPICAL FORMULATION FOR A JAK INHIBITOR
- Publication number 20220211712
- Publication date Jul 7, 2022
- INCYTE CORPORATION
- Bhavnish Parikh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB
- Publication number 20220211631
- Publication date Jul 7, 2022
- INCYTE CORPORATION
- Yong Ni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOPICAL FORMULATION FOR A JAK INHIBITOR
- Publication number 20220211707
- Publication date Jul 7, 2022
- INCYTE CORPORATION
- Bhavnish Parikh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR
- Publication number 20220016036
- Publication date Jan 20, 2022
- INCYTE CORPORATION
- Krishnaswamy Yeleswaram
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB
- Publication number 20210128477
- Publication date May 6, 2021
- INCYTE CORPORATION
- Yong Ni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOPICAL FORMULATION FOR A JAK INHIBITOR
- Publication number 20210000832
- Publication date Jan 7, 2021
- INCYTE CORPORATION
- Bhavnish Parikh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOPICAL FORMULATION FOR A JAK INHIBITOR
- Publication number 20200368240
- Publication date Nov 26, 2020
- INCYTE CORPORATION
- Bhavnish Parikh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR
- Publication number 20200253879
- Publication date Aug 13, 2020
- INCYTE CORPORATION
- Krishnaswamy Yeleswaram
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOPICAL FORMULATION FOR A JAK INHIBITOR
- Publication number 20200046707
- Publication date Feb 13, 2020
- INCYTE CORPORATION
- Bhavnish Parikh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB
- Publication number 20190231696
- Publication date Aug 1, 2019
- INCYTE CORPORATION
- Yong Ni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR
- Publication number 20170319487
- Publication date Nov 9, 2017
- INCYTE CORPORATION
- Krishnaswamy Yeleswaram
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOPICAL FORMULATION FOR A JAK INHIBITOR
- Publication number 20150250790
- Publication date Sep 10, 2015
- INCYTE CORPORATION
- Bhavnish Parikh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR
- Publication number 20150065484
- Publication date Mar 5, 2015
- INCYTE CORPORATION
- Krishnaswamy Yeleswaram
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB
- Publication number 20140135350
- Publication date May 15, 2014
- INCYTE CORPORATION
- Yong Ni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOPICAL FORMULATION FOR A JAK INHIBITOR
- Publication number 20110288107
- Publication date Nov 24, 2011
- BHAVNISH PARIKH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

BHAVNISH PARIKH

Person

Patents Grantslast 30 patents

Sustained-release dosage forms of ruxolitinib

Topical formulation for a JAK inhibitor

Sustained-release dosage forms of ruxolitinib

Sustained-release dosage forms of ruxolitinib

Topical formulation for a JAK inhibitor

Sustained-release dosage forms of ruxolitinib

Topical formulation for a JAK inhibitor

Sustained release dosage forms for a JAK1 inhibitor

Sustained-release dosage forms of ruxolitinib

Topical formulation for a JAK inhibitor

Topical formulation for a JAK inhibitor

Sustained release dosage forms for a JAK1 inhibitor

Sustained-release dosage forms of ruxolitinib

Sustained release dosage forms for a JAK1 inhibitor

Patents Applicationslast 30 patents

TOPICAL FORMULATION FOR A JAK INHIBITOR

TOPICAL FORMULATION FOR A JAK INHIBITOR

SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB

TOPICAL FORMULATION FOR A JAK INHIBITOR

TOPICAL FORMULATION FOR A JAK INHIBITOR

SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB

SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB

TOPICAL FORMULATION FOR A JAK INHIBITOR

SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB

TOPICAL FORMULATION FOR A JAK INHIBITOR

SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR

SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB

TOPICAL FORMULATION FOR A JAK INHIBITOR

TOPICAL FORMULATION FOR A JAK INHIBITOR

SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR

TOPICAL FORMULATION FOR A JAK INHIBITOR

SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB

SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR

TOPICAL FORMULATION FOR A JAK INHIBITOR

SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR

SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB

TOPICAL FORMULATION FOR A JAK INHIBITOR